---

---

symbols : Abbv    crawled time : 08:00   

save search

---

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
GSK | $39.6 -0.88% 0.0% 2.8M |

Health Technology

| -5.15% | O: 0.43% H: 0.67% C: 0.21%
BAX | News | $39.52 -0.13% 0.0% 2.8M |

Health Technology

| -0.03% | O: 0.21% H: 0.24% C: -1.04%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| -4.15% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M |

Health Technology

| -0.9% | O: 1.33% H: 0.0% C: 0.0%
BMRN | News S | $90.48 -0.43% -0.43% 1.3M |

Health Technology

| 1.44% | O: -0.38% H: 1.79% C: 0.22%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $264.07 -0.59% -0.59% 2.2M |

Health Technology

| -15.55% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

---

Allergan Aesthetics Showcases Commitment to Individuality, Innovation, and Integrity at IMCAS World Congress 2024
Published: 2024-01-25 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| -1.92% | O: -1.92% H: 0.0% C: 0.0%
congress world

---

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.594 43.47% 2.2K |

Health Technology

| -22.28% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $92.116 -2.18% 2.3K |

Health Technology

| 2.34% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -3.34% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | News | $9.34 -1.11% 690K |

Manufacturing

| -23.82% | O: -2.2% H: 0.0% C: -0.27%
TAK | $13.15 -0.61% 0.0% 1.6M |

Health Technology

| -6.61% | O: -0.64% H: 0.5% C: 0.5%
NVO | News | $124.53 0.88% 0.0% 2.6M |

Health Technology

| 28.63% | O: -0.42% H: 0.67% C: 0.25%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| -2.97% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $144.77 0.22% -0.01% 9.3M |

Health Technology

| -7.18% | O: -0.18% H: 0.0% C: 0.0%
LLY | News | $750.77 0.54% -0.04% 3.1M |

Health Technology

| 27.99% | O: 0.43% H: 0.0% C: 0.0%
BMY | $47.84 -0.87% -0.02% 12M |

Health Technology

| -3.79% | O: 0.2% H: 0.55% C: 0.1%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 10.92% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M |

Health Technology

| 0.85% | O: 1.07% H: 0.0% C: 0.0%
GILD | $66.94 -0.55% -0.55% 5.3M |

Health Technology

| -14.25% | O: 0.08% H: 1.45% C: 1.17%
AMGN | $264.07 -0.59% -0.59% 2.2M |

Health Technology

| -1.61% | O: -0.05% H: 0.3% C: -0.76%
reach market

---

Antibacterial Drugs Market to grow by USD 9.90 billion from 2022 to 2027 | Asia to account for 42% of market growth- Technavio
Published: 2023-10-04 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 15.03% | O: 1.69% H: 0.8% C: 0.8%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 13.75% | O: 17.72% H: 0.0% C: 0.0%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| -6.41% | O: -3.27% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M |

Health Technology

| 10.34% | O: 0.81% H: 0.19% C: -0.28%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 10.9% | O: -0.89% H: 0.0% C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M |

Health Technology

| -13.49% | O: 1.07% H: 0.0% C: 0.0%
antibacterial asia market

---

Regenerative Medicine Market Size to Hit USD 44.63 Billion by 2024, with at a 20.16% CAGR Over the Forecast Period | Brandessence Market Research
Published: 2023-09-26 (Crawled : 08:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 8.93% | O: -3.05% H: 1.75% C: 0.5%
SYK | $336.03 -0.48% 0.0% 1.1M |

Health Technology

| 16.93% | O: -0.92% H: 0.24% C: -3.93%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| -8.57% | O: -0.07% H: 0.46% C: -0.31%
BMY | $47.84 -0.87% -0.02% 12M |

Health Technology

| -18.42% | O: -0.49% H: 0.65% C: -0.56%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 7.4% | O: 1.16% H: 0.13% C: -0.32%
VCEL | $46.29 -2.59% -2.66% 320K |

Health Technology

| 36.06% | O: 0.38% H: 1.7% C: -1.85%
BIIB | $192.13 -1.55% -1.57% 1.3M |

Health Technology

| -23.48% | O: -0.02% H: 1.37% C: 1.21%
research market

---

Dry Eye Syndrome Drugs Market to grow by USD 2,159.21 million from 2022 to 2027; The growing geriatric population drives the market - Technavio
Published: 2023-08-09 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 17.85% | O: 1.92% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 12.8% | O: 1.11% H: 0.53% C: 0.53%
VTRS | $11.095 -0.22% -0.23% 6.1M |

Health Technology

| -0.45% | O: 0.0% H: 2.96% C: 0.99%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| -9.67% | O: -0.07% H: 0.73% C: 0.36%
GSK | $39.6 -0.88% 0.0% 2.8M |

Health Technology

| 13.21% | O: 0.14% H: 0.8% C: 0.43%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 8.69% | O: -0.16% H: 0.0% C: 0.0%
ABT | News | $105.9 -3.03% 0.07% 12M |

Health Technology

| 0.58% | O: -1.71% H: 0.0% C: 0.0%
growing eye market

---

U.S. FDA Approves QULIPTA® (atogepant) for Adults With Chronic Migraine
Published: 2023-04-18 (Crawled : 08:00) - biospace.com/
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 1.7% | O: -0.11% H: 0.14% C: -0.88%
qulipta fda migraine

---

Human papillomavirus (HPV) therapeutics market size to grow by USD 953.3 million between 2022 and 2027; Growth driven by advent of vaccines - Technavio
Published: 2023-04-11 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 6.46% | O: -0.69% H: 0.0% C: -0.77%
GSK | $39.6 -0.88% 0.0% 2.8M |

Health Technology

| 4.57% | O: -0.11% H: 0.0% C: -1.27%
AXTA | $31.78 0.76% 0.0% 1.9M |

Process Industries

| 5.41% | O: 1.27% H: 1.02% C: 0.5%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 1.64% | O: 0.13% H: 0.68% C: -0.07%
therapeutics growth market

---

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Crohn's Disease
Published: 2023-02-27 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 7.34% | O: 0.36% H: 0.97% C: 0.67%
rinvoq treatment disease abbvie chmp positive

---

Testosterone replacement therapy market: North America to account for 58% of market growth, Driven by initiatives to increase awareness about hypogonadism among the population - Technavio
Published: 2023-02-17 (Crawled : 08:00) - prnewswire.com
ENDPQ | $0.004 -50.0% 1.7M |

n/a

| -95.58% | O: 1.55% H: 3.26% C: 2.93%
VTRS | $11.095 -0.22% -0.23% 6.1M |

Health Technology

| -4.72% | O: -1.03% H: 2.08% C: 1.39%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| 8.28% | O: -0.24% H: 1.61% C: 1.52%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 9.63% | O: -0.25% H: 1.5% C: 1.45%
america therapy market

---

Lung cancer therapeutics market size to grow by USD 10,204.33 million: High prevalence of lung cancer remains key growth driver - Technavio
Published: 2022-12-08 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 14.06% | O: 1.92% H: 0.0% C: 0.0%
SNYNF | News | $92.116 -2.18% 2.3K |

Health Technology

| -1.83% | O: 0.5% H: 0.16% C: 0.16%
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| -0.51% | O: 2.24% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 23.48% | O: 0.0% H: 0.0% C: 0.0%
ALPMY | News | $9.34 -1.11% 690K |

Manufacturing

| -39.11% | O: 1.24% H: 0.97% C: 0.19%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| 1.47% | O: -1.17% H: 1.09% C: 1.01%
GSK | $39.6 -0.88% 0.0% 2.8M |

Health Technology

| 7.38% | O: -1.41% H: 1.75% C: 0.66%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| -0.89% | O: 0.0% H: 0.5% C: 0.36%
SNY | News | $46.125 0.71% 0.7% 3.7M |

Health Technology

| -2.83% | O: -1.32% H: 0.0% C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| -0.85% | O: 0.13% H: 0.76% C: 0.33%
AMGN | $264.07 -0.59% -0.59% 2.2M |

Health Technology

| -6.59% | O: 0.26% H: 0.03% C: -0.33%
lung therapeutics cancer growth market

---

AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation Congress
Published: 2022-12-06 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| -0.01% | O: 0.05% H: 0.22% C: -0.19%
migraine

---

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Moderate to Severe Active Crohn's Disease
Published: 2022-11-23 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 2.59% | O: 0.1% H: 0.62% C: -0.35%
skyrizi treatment disease active approval

---

Tyrosine Kinase Inhibitors Market Size to Grow by USD 19.07 Bn, North America to Account for 38% of Market Growth - Technavio
Published: 2022-10-20 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 40.86% | O: 4.6% H: 0.47% C: 0.4%
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 24.99% | O: -1.41% H: 2.96% C: 2.96%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| 21.66% | O: -0.82% H: 0.57% C: -0.43%
JNJ | News | $144.77 0.22% -0.01% 9.3M |

Health Technology

| -12.68% | O: -0.47% H: 0.45% C: 0.07%
GSK | $39.6 -0.88% 0.0% 2.8M |

Health Technology

| 26.48% | O: -0.42% H: 0.64% C: -0.38%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 14.53% | O: 0.02% H: 0.61% C: -0.16%
PBYI | $5.18 1.57% 1.54% 250K |

Health Technology

| 140.47% | O: 0.93% H: 2.07% C: -0.92%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 25.23% | O: -1.54% H: 2.07% C: 1.27%
AMGN | $264.07 -0.59% -0.59% 2.2M |

Health Technology

| 7.55% | O: -0.26% H: 0.61% C: -0.04%
america growth market

---

Male Hypogonadism Market Size to Grow by USD 684.95 Mn, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published: 2022-09-19 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 13.79% | O: -0.29% H: 0.15% C: -0.68%
LPCN | $4.76 -10.46% 34K |

Health Technology

| -44.81% | O: -1.23% H: 3.57% C: -0.54%
market

---

AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderate to Severe Crohn's Disease
Published: 2022-09-19 (Crawled : 08:00) - biospace.com/
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 13.79% | O: -0.29% H: 0.15% C: -0.68%
skyrizi treatment disease chmp risankizumab positive

---

AbbVie Presents Investigational Navitoclax Preliminary Data in JAK Inhibitor Naïve Myelofibrosis Patients
Published: 2022-06-10 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 9.54% | O: -3.55% H: 0.0% C: 0.0%

---

The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Risankizumab (SKYRIZI®) in Crohn's Disease
Published: 2022-05-27 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 7.75% | O: -1.98% H: 0.0% C: 0.0%
skyrizi disease lancet risankizumab results phase 3

---

The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Upadacitinib (RINVOQ®) in Ulcerative Colitis
Published: 2022-05-27 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 7.75% | O: -1.98% H: 0.0% C: 0.0%
rinvoq lancet results phase 3 ulcerative colitis

---

AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases
Published: 2022-03-11 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 10.8% | O: 1.15% H: 0.0% C: 0.0%
disease collaboration neuropsychiatric

---

Gainers vs Losers

56%

44%

Top 10 Gainers

INVO | $1.76 131.58% 56.82% 230M |

Health Technology

SINT | $0.0365 59.39% 37.26% 470M |

Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M |

Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M |

GCTK | $0.715 36.27% 26.62% 640K |

Manufacturing

TCON | $2.33 36.26% 26.61% 2M |

Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M |

KZIA | $0.38 30.58% 23.42% 300K |

Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M |

Health Technology

ATNF | $1.91 29.05% 22.51% 310K |

---

Your saved searches

---